These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 13595786)

  • 1. [Histological and bacteriological changes in lepromatous leprosy after treatment with diamino-diphenyl-sulfone (sulfone mère)].
    NICOLAU SG; VULCAN P
    Arch Klin Exp Dermatol; 1958; 207(5):486-98. PubMed ID: 13595786
    [No Abstract]   [Full Text] [Related]  

  • 2. [The 4:4 '-diamino diphenyl sulfone in the treatment of lepromatous leprosy].
    DUARTE LG; DE MELLO PH
    Rev Bras Leprol; 1953 Sep; 21(3):207-20. PubMed ID: 13167563
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diamino-diphenyl-sulfone, dihydrostreptomycin and p-aminosalicylic acid in the treatment of lepromatous leprosy].
    GONZALEZ OCHOA A; MARTINEZ BAEZ M; LAVALLE AGUILAR P; CASTRO ESTRADA S
    Bol Oficina Sanit Panam; 1952 Oct; 33(4):306-29. PubMed ID: 12977879
    [No Abstract]   [Full Text] [Related]  

  • 4. Relapses after sulfone therapy in leprosy of the lepromatous type.
    RODRIGUEZ JN
    Int J Lepr; 1959; 26(4):305-12. PubMed ID: 13672660
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of lepromatous leprosy with combined sulfone-streptomycin-hydrazide of isonicotinic acid].
    ORSINI O
    Arq Min Leprol; 1957 Jul; 17(3):291-4. PubMed ID: 13522478
    [No Abstract]   [Full Text] [Related]  

  • 6. [A single weekly oral dose of a sulfone-mère and dipropyl sulfone mixture as possible therapy in leprosy].
    FLOCH H; DEHEZ F; MAILLOUX M
    Bull Soc Pathol Exot Filiales; 1956; 49(5):855-67. PubMed ID: 13413618
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacteriological results of treatment of lepromatous cases with diaminodiphenyl sulfone by mouth for periods up to five years.
    ROY AT
    Int J Lepr; 1956; 24(1):45-50. PubMed ID: 13366482
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical evaluation studies in lepromatous leprosy; third series: nicotinamide, and BCG vaccination as supplements to diaminodiphenyl sulfone (DDS).
    DOULL JA; RODRIGUEZ JN; DAVISON AR; TOLENTINO JG; FERNANDEZ JV
    Int J Lepr; 1958; 26(3):219-35. PubMed ID: 13640759
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanism of action of sulfones in leprosy; activity of monoisopropyl sulfone and diisopropyl sulfone administered by mouth].
    DEHEZ F; FLOCH H
    Publ Inst Pasteur Guyane Fr Inini; 1956 Jul; 17(400):1-8. PubMed ID: 13395621
    [No Abstract]   [Full Text] [Related]  

  • 10. [Synergetic treatment of Hansen's disease with mild doses of sulfone mere, thiacetazone & chaulmoogra oil in weekly injections: first results; preliminary report].
    LAVIRON P; BEYTOUT D; JARDIN C
    Maroc Med; 1958 Jun; 37(397):668-70. PubMed ID: 13577040
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic activities of monoisopropyl sulfone and diisopropyl sulfone in leprosy].
    FLOCH H
    Publ Inst Pasteur Guyane Fr Inini; 1956 Jul; 17(401):1-6. PubMed ID: 13395622
    [No Abstract]   [Full Text] [Related]  

  • 12. Initial dosage of diaminodiphenyl sulfone in the treatment of tuberculoid leprosy.
    LEWIS RA; KYI-KYI K; EDWARDS R
    Int J Lepr; 1957; 25(4, Part 1):370-4. PubMed ID: 13562944
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sulfone therapy in lepromatous children at Colônia Santa Isabel, Brazil].
    ORSINI O; TAVARES I
    Arq Min Leprol; 1951 Jan; 11(1):16-33. PubMed ID: 14869252
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sulfone therapy of leprosy; fate of aminohydroxyethylaminodiphenylsulfone (1087 MM), monosubstituted sulfone administered orally; method of action].
    FLOCH H; LECUILLER A
    Bull Soc Pathol Exot Filiales; 1951; 44(9-10):527-30. PubMed ID: 14905210
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanism of action of sulfones in leprosy. XI. Mechanism of action of intramuscular monoethyl sulfone].
    FLOCH H; FAURAN P; MAILLOUX M
    Publ Inst Pasteur Guyane Fr Inini; 1957 May; 18(424):1-12. PubMed ID: 13522261
    [No Abstract]   [Full Text] [Related]  

  • 16. [Massive oral administration of a 1 gm. mixture of diaminodiphenylsulfone and dipropyl sulfone induces a blood sulfone level sufficiently high for leprosy therapy lasting for one week].
    FLOCH H
    Bull Acad Natl Med; 1956 Oct 16-23; 140(26-27):483-7. PubMed ID: 13396354
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood picture in sulfone treatment of leprosy; relation with the dose and blood concentration of the drugs.
    NAHAS L; RZEPPA H; LIMA Lde S
    Int J Lepr; 1954; 22(1):22-30. PubMed ID: 13201202
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bacteriological action of 1-(p-[N,N-dimethylaminolphenyl)-3-(p-n-butoxyphenyl)-2-thiorea on leprosy of the lepromatous type and on leprosy of the sulfone-resistant dimorphic type].
    MONTESTRUC E; BENOIST J
    Bull Soc Pathol Exot Filiales; 1960; 53():13-6. PubMed ID: 13848669
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of diaminodiphenylsulfone and thiosemicarbazone in the treatment of lepromatous leprosy; clinical and bacteriological evaluation in sixty hospitalized patients.
    SAGHER F; BRAND N
    Int J Lepr; 1953; 21(2):161-7. PubMed ID: 13096167
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sulfone therapy of ocular leprosy].
    AMENDOLA F
    Klin Monbl Augenheilkd Augenarztl Fortbild; 1955; 126(2):207-9. PubMed ID: 14382442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.